Please join us for a special seminar by Dr. Ivelin Georgiev (Vanderbilt University):
“Novel Platforms for Monoclonal Antibody Discovery”

Dr. Georgiev seeks to find innovative solutions for the treatment and prevention of disease and for the enhancement of human health through computational models of disease. His transformative approach employs the power of informatics to more rapidly advance healthcare for infectious diseases.  

His seminar will be of interest to research scientists across a wide range of disciplines, including life sciences, engineering, data science, chemistry, mathematics, and medicine.

Dr. Georgiev received his Ph.D. in Computer Science from Duke University and previously served as a staff scientist and co-head of the Structural Bioinformatics Core Section at the Vaccine Research Center at the NIH. He is currently a Professor in the Departments of Pathology, Microbiology, and Immunology; Biochemistry; Biomedical Informatics; Computer Science; and Chemical and Biomolecular Engineering at Vanderbilt. He is also the Director for the Vanderbilt Ph.D. Program in Chemical and Physical Biology, and is an Associate Director for the Vanderbilt Institute for Infection, Immunology, and Inflammation.

Dr. Georgiev is the founding Director of the Vanderbilt Center for Computational Microbiology and Immunology, which is focused on supporting research, educational, and strategic efforts that aim to employ the power of computation toward the development and application of innovative approaches for treatment and prevention of disease and for enhancement of human health. He has authored 100+ peer-reviewed publications in journals including Science, Nature, and Cell, and is an inventor on numerous issued patents, including for an FDA-approved vaccine.

All faculty, postdocs, graduate students, staff, and undergraduates are welcome.